Clinical trial
Subconjunctival Bevacizumab to Prevent Bleb Failure After Glaucoma Filtration…
NCT00468429 · Grewal Eye Institute, Other · Unknown status
Key facts
| NCT number | NCT00468429 |
|---|---|
| Title | Subconjunctival Bevacizumab to Prevent Bleb Failure After Glaucoma Filtration Surgery |
| Official title | Comparative Study of the Safety and Effectiveness Between Off-Label Subconjunctival Bevacizumab and Mitomycin C in Glaucoma Filtering Surgery. |
| Lead sponsor | Grewal Eye Institute, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Glaucoma |
| Intervention type | Drug |
| Interventions | Subconjunctival Bevacizumab |
| Enrollment | 40 |
| Start date | May 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | May 2, 2007 |
| Last update posted | Jun 4, 2007 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: